Related Experiment Video
Updated: Mar 18, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Proteomic analysis of breast tumors reveals functional impacts of genetic mutations. Researchers found that chromosome 5q deletions may drive EGFR overexpression in basal-like breast cancer by losing SKP1 and CETN3 genes.
Area of Science:
- Oncology
- Genomics
- Proteomics
Background:
- Somatic mutations play a role in cancer development.
- Understanding the functional consequences of these mutations is crucial for targeted therapies.
Purpose of the Study:
- To investigate the functional consequences of somatic mutations in breast cancer using proteomic analysis.
- To identify specific genetic alterations and their impact on protein expression in different breast cancer subtypes.
Main Methods:
- Proteomic analysis using mass spectrometry.
- Genomic characterization of 77 breast tumor samples.
Main Results:
- Identified functional consequences of somatic mutations through proteomic analysis.
- Observed EGFR overexpression in basal-like breast cancer.
- Linked EGFR overexpression to the loss of SKP1 and CETN3 genes due to chromosome 5q deletion in basal-like breast cancer.
Conclusions:
- The loss of SKP1 and CETN3 genes on chromosome 5q may be a driver of EGFR overexpression in basal-like breast cancer.
- Proteomic analysis is a valuable tool for uncovering the functional impact of genetic mutations in cancer.
More Related Videos
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
10:59Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
Related Concept Videos
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression